RecruitingNot Applicable

Scapulothoracic Stabilization and Postural Training in Upper Extremity Lymphedema

Turkey (Türkiye)60 participantsStarted 2026-03-01

Plain-language summary

This single-center randomized controlled trial aims to investigate the effects of adding scapulothoracic stabilization and postural training to standard lymphedema care in women with secondary upper extremity lymphedema following breast cancer surgery. Participants will be randomly assigned to receive either standard lymphedema care alone or standard care combined with scapulothoracic stabilization and postural training. Outcomes including scapular muscle strength, posture, upper extremity function, limb volume, and neck awareness will be assessed at baseline, immediately after treatment, and at a 2-month follow-up. The findings are expected to provide evidence regarding the effectiveness of incorporating targeted stabilization and postural exercises into conventional lymphedema rehabilitation.

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients aged 18 to 65 years. * Diagnosed with secondary upper extremity lymphedema following breast cancer surgery (mastectomy). * Willing to participate in the study. * Able to provide written informed consent. Exclusion Criteria: * Active infection (e.g., cellulitis or lymphangitis). * Advanced shoulder or cervical pathology. * Neurological disorders affecting upper extremity function. * Metastatic disease. * Receiving active chemotherapy. * Participation in another intensive lymphedema rehabilitation program within the previous 3 months.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Upper Extremity Function

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment

Change in Head Anterior Translation

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment

Change in Shoulder Height Asymmetry

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment.

Change in Shoulder Anterior Translation

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment.

Trial details

NCT IDNCT07697495

SponsorToros University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03

Contact for this trial

İdil Esin Ünlü, Assist. Prof. Dr.

+90 506 515 66 22 idil.unlu@toros.edu.tr

View on ClinicalTrials.gov More Secondary Lymphedema trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Upper Extremity Function

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment

Change in Head Anterior Translation

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment

Change in Shoulder Height Asymmetry

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment.

Change in Shoulder Anterior Translation

Timeframe: Baseline, immediately after completion of treatment, and 2 months after treatment.